Ticagrelor added to methotrexate improves rheumatoid arthritis disease severity.

Garshick, Michael S; Rosenthal, Pamela B; Luttrell-Williams, Elliot; Cronstein, Bruce N; Berger, Jeffrey S

Garshick, Michael S; Rosenthal, Pamela B; Luttrell-Williams, Elliot; Cronstein, Bruce N; Berger, Jeffrey S.

Garshick MS; Center for the Prevention of Cardiovascular Disease, Department of Medicine.
Rosenthal PB; Leon H. Charney Division of Cardiology, Department of Medicine.
Luttrell-Williams E; Division of Rheumatology, Department of Medicine.
Cronstein BN; Leon H. Charney Division of Cardiology, Department of Medicine.
Berger JS; Division of Rheumatology, Department of Medicine.

Rheumatology (Oxford) ; 60(11): 5473-5475, 2021 11 03.

Article en En | MEDLINE | ID: mdl-34142122

Asunto(s)

Antirreumáticos/uso terapéutico; Artritis Reumatoide/tratamiento farmacológico; Metotrexato/uso terapéutico; Antagonistas del Receptor Purinérgico P2Y/uso terapéutico; Ticagrelor/uso terapéutico; Adulto; Quimioterapia Combinada; Femenino; Humanos; Masculino; Persona de Mediana Edad; Prueba de Estudio Conceptual; Índice de Severidad de la Enfermedad

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Metotrexato / Antirreumáticos / Antagonistas del Receptor Purinérgico P2Y / Ticagrelor Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google